ArticleBMC chemistry2025
A convergence of synthesis and antimicrobial research: imidazolium based dicationic ionic liquids.
Article in BMC chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multiple Dynamic Covalent Bond Crosslinked Ionic Liquids-Based Hydrogel with Stretchable, Rapid Self-Healing and Antibacterial Activity Properties.Gels (Basel, Switzerland) · 2026Article
- An Oxygen-Responsive Metabolic Shift in Gut BacteriumJACS Au · 2026Article
- ImidazoliumRSC advances · 2026Article
- L-Glycine and L-leucine derived multifunctional ionic liquids for potential antibacterial applications: in-vitro and in-silico studies.BMC chemistry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rising challenge of developing effective antimicrobial agents to combat a broad spectrum of bacterial infections, while mitigating the risk of drug resistance, has prompted extensive exploration into alternative treatment strategies. This paper focuses on the synthesis and characterization of imidazolium-based dicationic ionic liquids with the aim of addressing this crucial healthcare need. A total of 16 distinct compounds were successfully synthesized and systematically characterized using Fourier-transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR) techniques. The investigation into the antibacterial activity of these ionic liquids showcased their potential as promising antimicrobial agents. Drawing on the advantageous properties of ionic liquids, such as reduced toxicity and outstanding antimicrobial efficacy. Our study specifically explores dicationic imidazolium-based ionic liquids with two different spacers: 1,3-dibromopropane and (E)-1,4-dibromobut-2-ene. Thorough analysis using
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.